Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Gross Profit: 2009-2024

Historic Gross Profit for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to $36.8 million.

  • Fortress Biotech's Gross Profit rose 16.91% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.1 million, marking a year-over-year decrease of 4.34%. This contributed to the annual value of $36.8 million for FY2024, which is 40.29% down from last year.
  • According to the latest figures from FY2024, Fortress Biotech's Gross Profit is $36.8 million, which was down 40.29% from $61.6 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Gross Profit registered a high of $61.6 million during FY2023, and its lowest value of $31.0 million during FY2020.
  • In the last 3 years, Fortress Biotech's Gross Profit had a median value of $45.0 million in 2022 and averaged $47.8 million.
  • As far as peak fluctuations go, Fortress Biotech's Gross Profit soared by 58.93% in 2020, and later tumbled by 40.29% in 2024.
  • Fortress Biotech's Gross Profit (Yearly) stood at $31.0 million in 2020, then rose by 18.39% to $36.7 million in 2021, then increased by 22.51% to $45.0 million in 2022, then soared by 37.03% to $61.6 million in 2023, then crashed by 40.29% to $36.8 million in 2024.